Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig A Harrison

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
The Journal of Biological Chemistry|February 6, 2009
A common biosynthetic pathway governs the dimerization and secretion of inhibin and related transforming growth factor beta (TGFbeta) ligandsKelly L Walton, Yogeshwar Makanji, Matthew C Wilce, et al.
The Journal of Biological Chemistry|April 10, 2008
Suppression of inhibin A biological activity by alterations in the binding site for betaglycanYogeshwar Makanji, Kelly L Walton, Matthew C Wilce, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2013
Growth differentiation factor 9:bone morphogenetic protein 15 (GDF9:BMP15) synergism and protein heterodimerizationDavid G Mottershead, Craig A Harrison, Thomas D Mueller, et al.
Endocrinology|April 8, 2016
A Novel, More Efficient Approach to Generate Bioactive InhibinsKelly L Walton, Emily K Kelly, Katharine E Johnson, et al.
Molecular and Cellular Endocrinology|August 6, 2013
Use of detergent-based buffers allows detection of precursor inhibin forms in an immunoassay formatKelly L Walton, Karen L Chan, Enid Pruysers, et al.
The Journal of Biological Chemistry|March 24, 2010
Two distinct regions of latency-associated peptide coordinate stability of the latent transforming growth factor-beta1 complexKelly L Walton, Yogeshwar Makanji, Justin Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2017
Specific targeting of TGF-β family ligands demonstrates distinct roles in the regulation of muscle mass in health and diseaseJustin L Chen, Kelly L Walton, Adam Hagg, et al.
Reproductive Biology and Endocrinology : RB&E|October 31, 2009
Expression of nodal signalling components in cycling human endometrium and in endometrial cancerIrene Papageorgiou, Peter K Nicholls, Fang Wang, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2011
2-Phenyl and 2-heterocyclic-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridines as inhibitors of TGF-β1 and activin A signallingRudy Ciayadi, Mahesh Potdar, Kelly L Walton, et al.
Cancer Research|June 23, 2016
Differential Effects of IL6 and Activin A in the Development of Cancer-Associated CachexiaJustin L Chen, Kelly L Walton, Hongwei Qian, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
The Journal of Biological Chemistry|February 6, 2009
A common biosynthetic pathway governs the dimerization and secretion of inhibin and related transforming growth factor beta (TGFbeta) ligandsKelly L Walton, Yogeshwar Makanji, Matthew C Wilce, et al.
The Journal of Biological Chemistry|April 10, 2008
Suppression of inhibin A biological activity by alterations in the binding site for betaglycanYogeshwar Makanji, Kelly L Walton, Matthew C Wilce, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2013
Growth differentiation factor 9:bone morphogenetic protein 15 (GDF9:BMP15) synergism and protein heterodimerizationDavid G Mottershead, Craig A Harrison, Thomas D Mueller, et al.
Endocrinology|April 8, 2016
A Novel, More Efficient Approach to Generate Bioactive InhibinsKelly L Walton, Emily K Kelly, Katharine E Johnson, et al.
Molecular and Cellular Endocrinology|August 6, 2013
Use of detergent-based buffers allows detection of precursor inhibin forms in an immunoassay formatKelly L Walton, Karen L Chan, Enid Pruysers, et al.
The Journal of Biological Chemistry|March 24, 2010
Two distinct regions of latency-associated peptide coordinate stability of the latent transforming growth factor-beta1 complexKelly L Walton, Yogeshwar Makanji, Justin Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2017
Specific targeting of TGF-β family ligands demonstrates distinct roles in the regulation of muscle mass in health and diseaseJustin L Chen, Kelly L Walton, Adam Hagg, et al.
Reproductive Biology and Endocrinology : RB&E|October 31, 2009
Expression of nodal signalling components in cycling human endometrium and in endometrial cancerIrene Papageorgiou, Peter K Nicholls, Fang Wang, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2011
2-Phenyl and 2-heterocyclic-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridines as inhibitors of TGF-β1 and activin A signallingRudy Ciayadi, Mahesh Potdar, Kelly L Walton, et al.
Cancer Research|June 23, 2016
Differential Effects of IL6 and Activin A in the Development of Cancer-Associated CachexiaJustin L Chen, Kelly L Walton, Hongwei Qian, et al.
Pageof 8